Ludwigshafen, Germany

Rolf Schlick

This inventor holds 1 USPTO granted patent. Top assignee: Basf Aktiengesellschaft. Active years: 1987.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rolf Schlick: Innovator in Imidazole Chemistry

Introduction

Rolf Schlick is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of chemistry, particularly in the preparation of imidazole-4(5)-monocarboxylic acids and their salts. His innovative work has implications for various applications, including dyes, crop protection agents, and pharmaceuticals.

Latest Patents

Rolf Schlick holds a patent for the "Preparation of imidazole-4(5)-monocarboxylic acids and their salts." This patent describes a process where an imidazole is reacted with carbon dioxide and an alkali metal carbonate, bicarbonate, or hydroxide at temperatures ranging from 140°C to 230°C and under pressures from 2 to 350 bar. The resulting imidazole-4(5)-monocarboxylic acids serve as valuable starting materials for the synthesis of various chemical products.

Career Highlights

Rolf Schlick is associated with BASF Aktiengesellschaft, a leading chemical company known for its innovative solutions and products. His work at BASF has allowed him to contribute to advancements in chemical processes and product development.

Collaborations

Throughout his career, Rolf Schlick has collaborated with esteemed colleagues, including Uwe Kempe and Toni Dockner. These collaborations have fostered a productive environment for innovation and research in the field of chemistry.

Conclusion

Rolf Schlick's contributions to the field of imidazole chemistry highlight his role as an inventor dedicated to advancing chemical processes. His patent and work at BASF demonstrate the importance of innovation in developing new materials and applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…